Mode
Text Size
Log in / Sign up
N/A Completed N=10 Randomized Single-blind Treatment

Clinical Evaluation of Investigational Multifocal Toric Contact Lenses

Presbyopia · Astigmatism
Source: ClinicalTrials.gov NCT03519282 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
May 2020
Primary outcomePrimary: Visual Acuity — -0.08; -0.06; 0.00; -0.01 logMAR

Summary

This non-dispensing study is to evaluate the clinical performance of a test multifocal toric silicone hydrogel contact lens compared to a marketed multifocal toric contact lens (control).

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Acuity
-0.08; -0.06; 0.00; -0.01; 0.02; 0.01
SECONDARY
Assessment of Visual Performance: Distance Navigation Tasks for Vision Quality and Clarity
93; 87
SECONDARY
Assessment of Visual Performance: Intermediate Task for Vision Quality and Clarity
95; 95
SECONDARY
Assessment of Visual Performance: Near Task for Vision Quality and Clarity
94; 90

Eligibility Criteria

Inclusion Criteria

  • Has had a self-reported oculo-visual examination in the last two years.
  • Is aged 40-75 years, inclusive and has full legal capacity to volunteer.
  • Has read and understood the participant information sheet.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is able to participate in Parts A and B related to this work.
  • Has a contact lens spherical prescription between +10.00 to -10.00D (inclusive).
  • Has an Add component to their spectacle refraction (between +0.75 and +2.50DS).
  • Has astigmatism between -0.75 and -5.75DC (based on the vertexed ocular refraction in each eye.
  • Can be satisfactorily fitted with the study lenses.
  • Is correctable to a visual acuity of 20/40 (0.30 logMAR) or better (in each eye) with their habitual vision correction or 20/25 (0.10 logMAR) best-corrected.
  • They have successfully worn soft contact lenses in the last six months
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination.
  • Has an up-to-date pair of spectacles.

Exclusion Criteria

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would, in the opinion of the investigator, affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye that would, in the opinion of the investigator, be problematic for their participation in the study.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Has a history of anaphylaxis or severe allergic reaction.
  • Has diabetes or an infectious or immunosuppressive disease which could contraindicate contact lens wear or pose a risk to the investigator.
  • They are pregnant or breast-feeding.
  • Is participating in any other type of eye-related clinical or research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03519282). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search